Our specialty pharmaceuticals, branded generics and consumer products play a role in helping millions of people live healthier lives and providing treatment to those affected by debilitating diseases. We remain committed to improving the health and well-being of people everywhere, profitably growing our businesses, and bringing value to our shareholders.

Stock Performance

Recent Events

J.P. Morgan Global Leveraged Finance Conference

03/02/26

Bausch Health Fourth-Quarter and Full-Year 2025 Earnings Presentation

02/18/26

44th Annual J.P. Morgan Healthcare Conference

01/14/26

General Investor Relations
Email: [email protected]
877-281-6642
514-856-3855 (Canada)

Powered by Sitecore